HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

2007 Banana Boat Line Promises Superior Protection, “Lighter” Feel

This article was originally published in The Rose Sheet

  • News

Executive Summary

Banana Boat's sunscreen offerings for 2007 boast enhanced protection, easier application and a less obtrusive feel on the skin

You may also be interested in...



Playtex Renews Hawaiian Tropic, Banana Boat Lines, Touting Luxury, Stability

Playtex is adding new products and working to reinforce the brand identities of Hawaiian Tropic and Banana Boat, the firm said at a Jan. 29 briefing

Playtex Renews Hawaiian Tropic, Banana Boat Lines, Touting Luxury, Stability

Playtex is adding new products and working to reinforce the brand identities of Hawaiian Tropic and Banana Boat, the firm said at a Jan. 29 briefing

Banana Boat Enhances Sunscreen Line In 2008 With Botanicals, AvoTriplex

Banana Boat is upgrading its product stable this year with added botanicals and increased use of its AvoTriplex technology, the company announced Jan. 29 at a New York press event

Table

View full table

Related Content

HBW Insight
HBW Insight
Tags:
Latest Headlines

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

See All
UsernamePublicRestriction

Register

RS014503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By